MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Balance Sheets Overview
Current Ratio
159.01%
Quick Ratio
141.20%
Cash Ratio
56.03%
Debt to Asset Ratio
67.35%
Unit: Thousand (K) dollars
Assets Breakdown
Accounts receivable, net of rese...
Cash and cash equivalents
Intangible assets, net
Others
Liabilities Breakdown
Additional paid-in capital
Accumulated deficit
Accounts payable
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
25,643
27,219
24,090
24,948
Accounts receivable, net of reserves
36,246
24,992
29,783
17,983
Inventory
8,156
9,292
9,624
11,818
Prepaid expenses and other current assets
2,736
3,464
3,376
1,638
Total current assets
72,781
64,967
66,873
56,387
Intangible assets, net
25,510
26,479
27,605
28,670
Operating lease right-of-use asset, net
65
88
111
134
Total assets
98,356
91,534
94,589
85,191
Accounts payable
8,049
8,202
8,851
11,557
Due to related party
405
472
455
755
Accrued expenses
31,831
26,102
27,567
21,193
Accrued interest
416
390
398
416
Income taxes payable
-
70
70
71
Term loan, short-term
5,000
2,500
-
5,625
Operating lease liability, short-term
69
94
101
98
Total current liabilities
45,770
37,830
37,442
39,715
Term loan, long-term, net of discount
20,472
22,873
25,277
19,534
Operating lease liability, long-term
-
-
18
44
Total liabilities
66,242
60,703
62,737
59,293
Common stock-Common Excluding Class
2
2
2
2
Common stock-Common Class A
1
1
1
1
Additional paid-in capital
133,111
131,516
130,307
123,106
Accumulated deficit
-101,000
-100,688
-98,458
-97,211
Total stockholders' equity
32,114
30,831
31,852
25,898
Total liabilities and stockholders' equity
98,356
91,534
94,589
85,191
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Accounts receivable, net
of reserves
$36,246K
(131.69%↑ Y/Y)
Cash and cash
equivalents
$25,643K
(26.36%↑ Y/Y)
Inventory
$8,156K
(-36.54%↓ Y/Y)
Prepaid expenses and
other current assets
$2,736K
(10.37%↑ Y/Y)
Total current assets
$72,781K
(41.96%↑ Y/Y)
Intangible assets, net
$25,510K
(-14.21%↓ Y/Y)
Operating lease
right-of-use asset, net
$65K
(-58.33%↓ Y/Y)
Total assets
$98,356K
(21.19%↑ Y/Y)
Total liabilities and
stockholders' equity
$98,356K
(21.19%↑ Y/Y)
Total liabilities
$66,242K
(6.99%↑ Y/Y)
Total stockholders'
equity
$32,114K
(66.86%↑ Y/Y)
Accumulated deficit
-$101,000K
(-6.43%↓ Y/Y)
Total current
liabilities
$45,770K
(13.07%↑ Y/Y)
Term loan,
long-term, net of discount
$20,472K
(-4.17%↓ Y/Y)
Additional paid-in capital
$133,111K
(16.62%↑ Y/Y)
Common stock-Common
Excluding Class
$2K
(100.00%↑ Y/Y)
Common stock-Common
Class A
$1K
(0.00%↑ Y/Y)
Accrued expenses
$31,831K
(41.13%↑ Y/Y)
Accounts payable
$8,049K
(-36.89%↓ Y/Y)
Term loan,
short-term
$5,000K
(233.33%↑ Y/Y)
Accrued interest
$416K
(0.00%↑ Y/Y)
Due to related party
$405K
(-51.79%↓ Y/Y)
Operating lease
liability, short-term
$69K
(-28.13%↓ Y/Y)
Buy us a coffee
Journey Medical Corp (DERM)
Journey Medical Corp (DERM)